Receptor-mediated suppression of potassium currents requires colocalization within lipid rafts

Mol Pharmacol. 2009 Dec;76(6):1279-89. doi: 10.1124/mol.109.058008. Epub 2009 Sep 2.

Abstract

Expression of KCNQ2/3 (Kv7.2 and -7.3) heteromers underlies the neuronal M current, a current that is suppressed by activation of a variety of receptors that couple to the hydrolysis of phosphatidylinositol 4,5-bisphosphate. Expression of Kv7.2/7.3 channels in human embryonic kidney (HEK) 293 cells produced a noninactivating potassium current characteristic of M current. Muscarinic receptors endogenous to HEK293 cells were identified as being M3 by pharmacology and Western blotting, producing a rise of intracellular calcium ([Ca2+](i)) upon activation. Activation of these endogenous muscarinic receptors however, failed to suppress expressed Kv7.2/7.3 current. Current suppression was reconstituted by coexpression of HA-tagged muscarinic m1 or m3 receptors. Examination of membrane fractions showed that both expressed receptors and Kv7.2 and -7.3 channel subunits resided within lipid rafts. Disruption of lipid rafts by pretreatment of cells expressing either m1 or m3 muscarinic receptors with methyl-beta-cyclodextrin produced a loss of localization of proteins within lipid raft membrane fractions. This pretreatment also abolished both the increase of [Ca2+](i) and suppression of expressed Kv7.2/7.3 current evoked by activation of expressed m1 or m3 muscarinic receptors. A similar loss of muscarinic receptor-mediated suppression of M current native to rat dorsal root ganglion neurons was observed after incubating dissociated cells with methyl-beta-cyclodextrin. These data suggested that lipid rafts colocalized both muscarinic receptors and channel subunits to enable receptor-mediated suppression of channel activity, a spatial colocalization that enables specificity of coupling between receptor and ion channel.

MeSH terms

  • Animals
  • Blotting, Western
  • Calcium / metabolism
  • Carbachol / pharmacology
  • Cell Line
  • Cholinergic Agents / pharmacology
  • Ganglia, Spinal / cytology
  • Humans
  • KCNQ2 Potassium Channel / drug effects
  • KCNQ2 Potassium Channel / metabolism
  • KCNQ3 Potassium Channel / drug effects
  • KCNQ3 Potassium Channel / metabolism
  • Membrane Microdomains / drug effects*
  • Membrane Microdomains / metabolism
  • Membrane Potentials / drug effects
  • Mice
  • Muscarine / pharmacology
  • Oxotremorine / pharmacology
  • Phosphatidylinositol 4,5-Diphosphate / pharmacology
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels / drug effects*
  • Receptor, Muscarinic M1 / drug effects
  • Receptor, Muscarinic M3 / drug effects
  • Receptors, Muscarinic / drug effects

Substances

  • Cholinergic Agents
  • KCNQ2 Potassium Channel
  • KCNQ3 Potassium Channel
  • Phosphatidylinositol 4,5-Diphosphate
  • Potassium Channel Blockers
  • Potassium Channels
  • Receptor, Muscarinic M1
  • Receptor, Muscarinic M3
  • Receptors, Muscarinic
  • Oxotremorine
  • Muscarine
  • Carbachol
  • Calcium